CONCLUSION CTC testing can potentially serve as a tool for minimal residual disease detection in early-staged lung cancer after curative surgery.CDK7, a transcriptional cyclin-dependent kinase, is emerging as a novel cancer target. Triple-negative breast cancers (TNBC) but not estrogen receptor-positive (ER+) breast cancers have been reported to…[Read more]